A lay person's perspective on starting and stopping clinical trials.
- Published in:
- Statistics in Medicine, 1994, v. 13, n. 13/14, p. 1473, doi. 10.1002/sim.4780131324
- By:
- Publication type:
- Article
Works matching IS 02776715 AND DT 1994 AND VI 13 AND IP 13/14
Results: 27
1
2
A reversal of fortune: Practical problems in the monitoring and interpretation of an EORTC breast cancer trial.
- Published in:
- Statistics in Medicine, 1994, v. 13, n. 13/14, p. 1329, doi. 10.1002/sim.4780131306
- By:
- Publication type:
- Article
3
Triangular test and randomized trials: Practical problems in a small cell lung cancer trial.
- Published in:
- Statistics in Medicine, 1994, v. 13, n. 13/14, p. 1415, doi. 10.1002/sim.4780131317
- By:
- Publication type:
- Article
4
Masthead.
- Published in:
- Statistics in Medicine, 1994, v. 13, n. 13/14, p. fmi, doi. 10.1002/sim.4780131301
- Publication type:
- Article
5
The what, why and how of bayesian clinical trials monitoring.
- Published in:
- Statistics in Medicine, 1994, v. 13, n. 13/14, p. 1371, doi. 10.1002/sim.4780131312
- By:
- Publication type:
- Article
6
Discussion of 'early stopping rules - clinical perspectives and ethical considerations'.
- Published in:
- Statistics in Medicine, 1994, v. 13, n. 13/14, p. 1471, doi. 10.1002/sim.4780131323
- By:
- Publication type:
- Article
7
Stopping a clinical trial early: Frequentist and bayesian approaches applied to a CALGB trial in non-small-cell lung cancer.
- Published in:
- Statistics in Medicine, 1994, v. 13, n. 13/14, p. 1313, doi. 10.1002/sim.4780131305
- By:
- Publication type:
- Article
8
The case against independent monitoring committees.
- Published in:
- Statistics in Medicine, 1994, v. 13, n. 13/14, p. 1411, doi. 10.1002/sim.4780131316
- By:
- Publication type:
- Article
9
Conclusions. 2.
- Published in:
- Statistics in Medicine, 1994, v. 13, n. 13/14, p. 1493, doi. 10.1002/sim.4780131327
- By:
- Publication type:
- Article
10
Discussion of 'interim analysis: The alpha spending approach'.
- Published in:
- Statistics in Medicine, 1994, v. 13, n. 13/14, p. 1353, doi. 10.1002/sim.4780131309
- By:
- Publication type:
- Article
11
Discussion of 'sequential methods based on the boundaries approach for the clinical comparison of survival times'.
- Published in:
- Statistics in Medicine, 1994, v. 13, n. 13/14, p. 1369, doi. 10.1002/sim.4780131311
- By:
- Publication type:
- Article
12
Early stopping rules - clinical perspectives and ethical considerations.
- Published in:
- Statistics in Medicine, 1994, v. 13, n. 13/14, p. 1459, doi. 10.1002/sim.4780131322
- By:
- Publication type:
- Article
13
The chart trials: Bayesian design and monitoring in practice.
- Published in:
- Statistics in Medicine, 1994, v. 13, n. 13/14, p. 1297, doi. 10.1002/sim.4780131304
- By:
- Publication type:
- Article
14
Some practical aspects of the interim monitoring of clinical trials.
- Published in:
- Statistics in Medicine, 1994, v. 13, n. 13/14, p. 1401, doi. 10.1002/sim.4780131315
- By:
- Publication type:
- Article
15
Conclusions. 1: The relationship between clinical trials and clinical practice: The risks of underestimating its complexity.
- Published in:
- Statistics in Medicine, 1994, v. 13, n. 13/14, p. 1485, doi. 10.1002/sim.4780131326
- By:
- Publication type:
- Article
16
Interim analysis: The alpha spending function approach.
- Published in:
- Statistics in Medicine, 1994, v. 13, n. 13/14, p. 1341, doi. 10.1002/sim.4780131308
- By:
- Publication type:
- Article
17
Discussion of 'surrogate markers in aids and cancer trials'.
- Published in:
- Statistics in Medicine, 1994, v. 13, n. 13/14, p. 1437, doi. 10.1002/sim.4780131319
- By:
- Publication type:
- Article
18
Sequential methods based on the boundaries approach for the clinical comparison of survival times.
- Published in:
- Statistics in Medicine, 1994, v. 13, n. 13/14, p. 1357, doi. 10.1002/sim.4780131310
- By:
- Publication type:
- Article
19
Stopping when the experimental regimen does not appear to help.
- Published in:
- Statistics in Medicine, 1994, v. 13, n. 13/14, p. 1453, doi. 10.1002/sim.4780131321
- By:
- Publication type:
- Article
20
The clinical importance of early stopping of randomized trials in cancer treatments.
- Published in:
- Statistics in Medicine, 1994, v. 13, n. 13/14, p. 1293, doi. 10.1002/sim.4780131303
- By:
- Publication type:
- Article
21
Data monitoring committees and early stopping guidelines: The southwest oncology group experience.
- Published in:
- Statistics in Medicine, 1994, v. 13, n. 13/14, p. 1391, doi. 10.1002/sim.4780131314
- By:
- Publication type:
- Article
22
Early stopping of prevention trials when multiple outcomes are of interest: A discussion.
- Published in:
- Statistics in Medicine, 1994, v. 13, n. 13/14, p. 1479, doi. 10.1002/sim.4780131325
- By:
- Publication type:
- Article
23
Timing the collaborative analysis of three trials comparing 5-FU plus folinic acid (FUFA) to surgery alone in the management of resected colorectal cancer: A national cancer institute of canada clinical trials group (NCIC-CTG) perspective.
- Published in:
- Statistics in Medicine, 1994, v. 13, n. 13/14, p. 1337, doi. 10.1002/sim.4780131307
- By:
- Publication type:
- Article
24
Surrogate markers in aids and cancer trials.
- Published in:
- Statistics in Medicine, 1994, v. 13, n. 13/14, p. 1423, doi. 10.1002/sim.4780131318
- By:
- Publication type:
- Article
25
Monitoring multi-armed trials.
- Published in:
- Statistics in Medicine, 1994, v. 13, n. 13/14, p. 1441, doi. 10.1002/sim.4780131320
- By:
- Publication type:
- Article
26
1289-1291Participants and authors.
- Published in:
- Statistics in Medicine, 1994, v. 13, n. 13/14, p. 1289, doi. 10.1002/sim.4780131302
- Publication type:
- Article
27
Discussion of 'the what, why and how of bayesian clinical trials monitoring'.
- Published in:
- Statistics in Medicine, 1994, v. 13, n. 13/14, p. 1385, doi. 10.1002/sim.4780131313
- By:
- Publication type:
- Article